Mr. Takashi Shimada has been promoted to President & CEO of PhoenixBio Co., Ltd. (Hiroshima, Japan) effective on June 28th, 2018. Mr. Kenji Kuramoto will continue as a Chairman of Board of Director of the company.
Mr. Yoshio Morikawa has been promoted to President & CEO of PhoenixBio USA Corporation (New York, NY, USA), a subsidiary of PhoenixBio Co., Ltd. effective on June 28th, 2018. Mr. Takashi Shimada will continue as a Chairman of Board of Director of the company.
PhoenixBio Co., Ltd. today announced that it has entered into a definitive agreement to acquire KMT Hepatech, Inc., a privately held contract research organization focused on providing services with a chimeric mouse model. KMT will wholly become a part of the PhoenixBio group effective November 30th, 2017.